• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

IMCS at SOFT 2025

WELCOME, ENZYME EXPERT

Ready to get started? Contact us today for a free sample!

Get Started

IMCS Poster Presentation Download

PO_ENZ_SOFT_2025_thumb

Poster #P-013
Hydrolysis of Drug Glucuronides by β-Glucuronidase is Contingent on Both pH and N- or O-Glucuronide Linkage

Abstract Expand

Introduction:

Opiate and opioid metabolism primarily occurs in the liver, and these drugs are removed from the body by glucuronidation and sulfation to facilitate excretion in urine. Drug testing laboratories can quantify free opiates and opioids in urine by LC-MS/MS by hydrolysis with a β-glucuronidase (β-GUS) and/or sulfatase. The activity of the β-glucuronidases will be affected both by the pH of the solution and the aglycone moiety of the drug glucuronide. Furthermore, for a single β-GUS, different drug glucuronides may display different pH optimums which is a consequence of aglycone functional groups and glucuronide linkage.

Objectives:

Compare the activities of commercially available β-glucuronidase enzymes on O-linked and N-linked drug glucuronides in different pH buffers.

Methods:

Deuterated and reference standards for morphine, oxymorphone, codeine, O-desmethyltramadol, O-desmethylvenlafaxine, amitriptyline, and nortriptyline were purchased from Cerilliant. All other reagents were purchased from MilliporeSigma or Fisher Scientific. Four β-glucuronidases were expressed and purified at IMCS: modified Escherichia coli β-GUS (E1F), Aspergillus chimera β-GUS (R3), Eubacterium eligens β-GUS (EeGUS), and Brachyspira pilosicoli (B. pi.) β-GUS variant (BpiGUS). A triple buffer system of Tris, Acetate, and MES was used from pH 4-9. Calibration curves include parent and glucuronide standards. Reactions were stopped by transferring sample into methanol (40%). Samples were further diluted and injected on a Thermo Scientific™ Vanquish™ UHPLC system coupled with a Thermo Scientific™ Endura™ Triple Quadrupole Mass Spectrometer. Analytes were separated using a Phenomenex Kinetex® 2.6 μm Biphenyl 100 Å, 50 x 4.6 mm column. Mobile phase A and B were 0.1% formic acid in water and 0.1% formic acid in acetonitrile, respectively.

Results:

The pH optimum was dependent on both the enzyme and the linkage (O- or N-) of the sugar to the drug aglycone. For O-linked drug glucuronides, E1F and BpiGUS favored neutral to basic pH while β-GUS Variant R3 and EeGUS had preference in acidic buffers. However, when N-linked drug glucuronides were hydrolyzed by the same enzymes, the pH optima of all enzymes shifted towards a more basic pH.

Discussion:

The β-GUS enzymes characterized here display variable pH optimums on drug glucuronides. Additionally, the pH optimum changes per enzyme based on whether the drug glucuronide is O-linked or N-linked, and the O-linked drug glucuronides are generally hydrolyzed at lower pH than N-linked drug glucuronides relative to each enzyme tested. The change in pH optimum based on sugar linkage may be related to the pKa of the amine in the N-linked drug glucuronides. When analyzing and comparing different β-GUS enzymes, the pH of the reaction buffer and sugar linkage of the target substrate(s) should be acknowledged in order to achieve optimal hydrolysis.

Download PDF

RELATED CONTENT:

  • IMCSzyme® RT
  • IMCSzyme® RT Facts
  • App Note: Hydrolyzing 30,000 ng/mL of Codeine-6- β-Glucuronide in 15 minutes with IMCSzyme®
  • Learn More About Natural Inhibitors in Urine
https://imcstips.com/wp-content/uploads/2023/10/ENZ_RT_Words_Animate_Scroll_V1.mp4

Sidebar

"*" indicates required fields

Name*
Email me a copy
Consent

Customize Your Workflow

IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

VIEW OUR CUSTOM SOLUTIONS

ABOUT IMCS

INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

STAY UP TO DATE

WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
Sign up to receive exclusive emails and offers from IMCS.
!
!
!
Subscribe
Something went wrong. Please check your entries and try again.

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

Return to top

Caleb-Schlachter-for-web

Caleb R. Schlachter, Ph.D.

Principal Scientist
Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
Gray Amick for web

Gray D. Amick, Ph.D.

Director of Operations
Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
Amanda M Headshot

Amanda C. McGee

Research Scientist
Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
Andrew_Headshot

L. Andrew Lee, Ph.D.

Co-Founder and Chief Scientific Officer
L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

Get started with 2N1 below

"*" indicates required fields

Name*
Would you be interested in joining the 2N1 beta program?*
Which product are you interested in? (select all that apply)*
What are your current purification workflows? (select all that apply)*
Please select your automation platform(s) (select all that apply)*
How soon are you planning on evaluating 2N1?*
Consent*

DOWNLOAD OUR POSTERS

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*